Cite
MLA Citation
Patrick Schöffski et al.. “Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.” European journal of cancer, vol. 156, 2021, pp. 12–23. http://access.bl.uk/ark:/81055/vdc_100144486235.0x000019